Pfizer, the US pharmaceutical group, said it is examining shedding its animal health and nutrition units as part of its efforts to streamline its activities, while retaining its generics business.
The move comes after the company earlier this year said it was reviewing its mix of businesses, at a time of investor criticism over poor returns.
via ft.com
No comments:
Post a Comment